Top

Osteoporosis International

Published in:

Open Access 01-11-2018 | Original Article

Association between use of antidepressants or benzodiazepines and the risk of subsequent fracture among those aged 65+ in the Netherlands

Authors: L. I. van de Ven, C. Klop, J. A. Overbeek, F. de Vries, A. M. Burden, P. K. Janssen

Published in: Osteoporosis International | Issue 11/2018

Abstract

Summary

This is the first study to examine the association between antidepressant and benzodiazepine use following a MOF and risk of subsequent fracture in those 65+. Using national data, drug use following MOF showed that the 1-year fully adjusted risk of subsequent MOF in those on antidepressants was more than doubled.

Introduction

We evaluated the association between the use of antidepressants or benzodiazepines and the risk of a subsequent major osteoporotic fracture.

Methods

A cohort study was performed using the Dutch PHARMO Database Network. Between 2002 and 2011, a total of 4854 patients sustained a first major osteoporotic fracture after the age of 65 years, of which 1766 sustained a hip fracture. Incidence rates and adjusted hazard ratios were calculated using Cox proportional hazards models.

Results

Within 1 year following a major osteoporotic fracture, 15% (95% CI 13.7–15.7) and 31% (95% CI 30.1–32.8) of patients were dispensed an antidepressant or benzodiazepine, respectively. Current use of antidepressants in the first year following a major osteoporotic fracture was associated with subsequent fracture (adjusted HR 2.17 (95% CI 1.37–3.43)). Recent and past use of antidepressants were also associated with an increased risk of subsequent fracture. When the complete follow-up period was included, only the current use of antidepressants was associated with subsequent fracture following a major osteoporotic fracture (adjusted HR 1.48; 95% CI 1.06–2.06). Current benzodiazepine use was not associated with an increased risk of fracture within 1 year following a major osteoporotic fracture (adjusted HR 1.18; 95% CI 0.76–1.81) or during the complete follow-up period (adjusted HR 1.18; 95% CI 0.90–1.55).

Conclusion

This study provides evidence that antidepressants should be used with caution following a major osteoporotic fracture. It provides needed insights that can be used to inform clinicians when assessing subsequent fracture risk in patients.

Kanis JA (2007) WHO technical report, University of Sheffield, UK:66

Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726–1733CrossRef

Lötters FJ, van den Bergh JP, de Vries F, Rutten-van Mölken MP (2016) Current and future incidence and costs of osteoporosis-related fractures in the Netherlands: combining claims data with BMD measurements. Calcif Tissue Int 98(3):235–243CrossRef

Takkouche B, Montes-Martínez A, Gill SS, Etminan M (2007) Psychotropic medications and the risk of fracture: a meta-analysis. Drug Saf 30(2):171–184CrossRef

Diem SJ, Blackwell TL, Stone KL, Yaffe K, Haney EM, Bliziotes MM, Ensrud KE (2007) Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 167(12):1240–1245CrossRef

Rauma PH, Honkanen RJ, Williams LJ, Tuppurainen MT, Kröger HP, Koivumaa-Honkanen H (2016) Effects of antidepressants on postmenopausal bone loss—a 5-year longitudinal study from the OSTPRE cohort. Bone 89:25–31CrossRef

Richards JB, Papaioannou A, Adachi JD, Joseph L, Whitson HE, Prior JC, Goltzman D, Canadian Multicentre Osteoporosis Study Research Group (2007) Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 167(2):188–194CrossRef

Moura C, Bernatsky S, Abrahamowicz M, Papaioannou A, Bessette L, Adachi J, Goltzman D, Prior J, Kreiger N, Towheed T, Leslie WD, Kaiser S, Ioannidis G, Pickard L, Fraser LA, Rahme E (2014) Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS). Osteoporos Int 25(5):1473–1481CrossRef

Greendale GA, Unger JB, Rowe JW, Seeman TE (1999) The relation between cortisol excretion and fractures in healthy older people: results from the MacArthur studies-Mac. J Am Geriatr Soc 47:799–803CrossRef

10.

Rabenda V, Nicolet D, Beaudart C, Bruyère O, Reginster JY (2013) Relationship between use of antidepressants and risk of fractures: a meta-analysis. Osteoporos Int 24(1):121–137CrossRef

11.

Xing D, Ma XL, Ma JX, Wang J, Yang Y, Chen Y (2014) Association between use of benzodiazepines and risk of fractures: a meta-analysis. Osteoporos Int 25(1):105–120CrossRef

12.

Kanis JA, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35(2):375–382CrossRef

13.

Haentjens P, Autier P, Collins J, Velkeniers B, Vanderschueren D, Boonen S (2003) Colles fracture, spine fracture, and subsequent risk of hip fracture in men and women. A meta-analysis. J Bone Joint Surg Am 85-A(10):1936–1943CrossRef

14.

Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15(4):721–739CrossRef

15.

Warriner AH, Patkar NM, Yun H, Delzell E (2011) Minor, major, low-trauma, and high-trauma fractures: what are the subsequent fracture risks and how do they vary? Curr Osteoporos Rep 9(3):122–128CrossRef

16.

Lönnroos E, Kautiainen H, Karppi P, Hartikainen S, Kiviranta I, Sulkava R (2007) Incidence of second hip fractures. A population-based study. Osteoporos Int 18(9):1279–1285CrossRef

17.

Kaukonen JP, Lüthje P, Nurmi-Lüthje I, Kataja M, Naboulsi H (2011) Second hip fracture and patients' medication after the first hip fracture: a follow-up of 221 hip fracture patients in Finland. Arch Gerontol Geriatr 52(2):185–189CrossRef

18.

Herings RMC, Stricker BHC, de Boer A, Bakker A, Stmnum F, Stergachis A (1996) Current use of thiazide diuretics and prevention of femur fractures. J Clin Epidemiol 49:115–119CrossRef

19.

Mickey RM, Greenland S (1989) The impact of confounder selection criteria on effect estimation. Am J Epidemiol 129(1):125–137CrossRef

20.

Leipzig RM, Cumming RG, Tinetti ME (1999) Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 47(1):30–39CrossRef

21.

22.

23.

Diem SJ, Ruppert K, Cauley JA, Lian Y, Bromberger JT, Finkelstein JS, Greendale GA, Solomon DH (2013) Rates of bone loss among women initiating antidepressant medication use in midlife. J Clin Endocrinol Metab 98(11):4355–4363CrossRef

24.

Mehdi T (2012) Benzodiazepines revisited. BJMP 5(1):a501

25.

van Strien AM, Koek HL, van Marum RJ, Emmelot-Vonk MH (2013) Psychotropic medications, including short acting benzodiazepines, strongly increase the frequency of falls in elderly. Maturitas 74(4):357–362CrossRef

26.

Donnelly K, Bracchi R, Hewitt J, Routledge PA, Carter B (2017) Benzodiazepines, Z-drugs and the risk of hip fracture: a systematic review and meta-analysis. BPLoS One 12(4):e0174730CrossRef

27.

Statistics Netherlands, STATLINE: “hospitalizations by sex, age, region and diagnosis ISHTM classification”. www.statline.cbs.nl, accessed 17 January 2018

28.

Nederlands Huisartsen Genootschap (NHG), de Nederlandse Vereniging voor Klinische Geriatrie (NVKG), Orde van Medische Specialisten (OMS). Multidisciplinaire richtlijn polyfarmacie bij ouderen 2012, https://www.nhg.org/themas/publicaties/multidisciplinaire-richtlijn-polyfarmacie-bij-ouderen assessed 05-02-2017

Title: Association between use of antidepressants or benzodiazepines and the risk of subsequent fracture among those aged 65+ in the Netherlands
Authors: L. I. van de Ven
C. Klop
J. A. Overbeek
F. de Vries
A. M. Burden
P. K. Janssen
Publication date: 01-11-2018
Publisher: Springer London
Published in: Osteoporosis International / Issue 11/2018
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-018-4632-4

At a glance: The STEP trials

Springer Medicine

Association between use of antidepressants or benzodiazepines and the risk of subsequent fracture among those aged 65+ in the Netherlands

Abstract

Summary

Introduction

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2018

A modification and validation of quantitative morphometry classification system for osteoporotic vertebral compressive fractures in mainland Chinese

Does primary lactase deficiency reduce bone mineral density in postmenopausal women? A systematic review and meta-analysis

Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus

Bone mineral density and vertebral fractures and their relationship with pulmonary dysfunction in patients with chronic obstructive pulmonary disease

Correction to: Differences in bone quality and strength between Asian and Caucasian young men

VITamin D and OmegA-3 TriaL (VITAL) bone health ancillary study: clinical factors associated with trabecular bone score in women and men